These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8115668)

  • 21. Long-term therapy for depression with trazodone.
    Fabre LF; Feighner JP
    J Clin Psychiatry; 1983 Jan; 44(1):17-21. PubMed ID: 6337131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of trazodone on EEG sleep and clinical state in major depression.
    van Bemmel AL; Havermans RG; van Diest R
    Psychopharmacology (Berl); 1992; 107(4):569-74. PubMed ID: 1603901
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Atypical antidepressants versus imipramine in the treatment of major depression: a meta-analysis.
    Workman EA; Short DD
    J Clin Psychiatry; 1993 Jan; 54(1):5-12. PubMed ID: 8428898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A double blind comparison of the efficacy and safety of trazodone and imipramine in endogenous depression.
    Al-Yassiri MM; Ankier SI; Bridges PK
    J Affect Disord; 1983 Nov; 5(4):333-40. PubMed ID: 6229564
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of fluoxetine on mood and immune status in depressed patients with HIV illness.
    Rabkin JG; Rabkin R; Wagner G
    J Clin Psychiatry; 1994 Mar; 55(3):92-7. PubMed ID: 7915270
    [TBL] [Abstract][Full Text] [Related]  

  • 26. New antidepressants--the serotonin reuptake inhibitors.
    Awad AG
    Psychiatr J Univ Ott; 1987 Mar; 12(1):31-4. PubMed ID: 2954176
    [No Abstract]   [Full Text] [Related]  

  • 27. Trazodone. A comparative clinical and predictive study.
    Kerr TA; McClelland HA; Stephens DA; Ankier SI
    Acta Psychiatr Scand; 1984 Dec; 70(6):573-7. PubMed ID: 6395636
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting with major depressive disorder.
    Fava M; McCall WV; Krystal A; Wessel T; Rubens R; Caron J; Amato D; Roth T
    Biol Psychiatry; 2006 Jun; 59(11):1052-60. PubMed ID: 16581036
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A double-blind, placebo controlled study of trazodone in patients with obsessive-compulsive disorder.
    Pigott TA; L'Heureux F; Rubenstein CS; Bernstein SE; Hill JL; Murphy DL
    J Clin Psychopharmacol; 1992 Jun; 12(3):156-62. PubMed ID: 1629380
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Acute stimulant response prediction of chronic trazodone effects.
    Little KY; Gay TL
    Prog Neuropsychopharmacol Biol Psychiatry; 1996 Jul; 20(5):815-24. PubMed ID: 8870066
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A comparison of venlafaxine, trazodone, and placebo in major depression.
    Cunningham LA; Borison RL; Carman JS; Chouinard G; Crowder JE; Diamond BI; Fischer DE; Hearst E
    J Clin Psychopharmacol; 1994 Apr; 14(2):99-106. PubMed ID: 8195464
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A comparison of the effect of fluoxetine and trazodone on the cognitive functioning of depressed outpatients.
    Fudge JL; Perry PJ; Garvey MJ; Kelly MW
    J Affect Disord; 1990 Apr; 18(4):275-80. PubMed ID: 2140380
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clinical assessment and performance tasks in depression: a comparison of amitriptyline and trazodone.
    Botros WA; Ankier SI; Priest RG; McManus IC; Steinert J; Samir ZY
    Br J Psychiatry; 1989 Oct; 155():479-82. PubMed ID: 2692763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. How long should patients with psychotic depression stay on the antipsychotic medication?
    Rothschild AJ; Duval SE
    J Clin Psychiatry; 2003 Apr; 64(4):390-6. PubMed ID: 12716238
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Thyroid indices and response to fluoxetine and nortriptyline in major depression.
    Gendall KA; Joyce PR; Mulder RT; Luty SE
    J Psychopharmacol; 2003 Dec; 17(4):431-7. PubMed ID: 14870956
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The efficacy of fluoxetine combined with a heterocyclic antidepressant in treatment-resistant depression: a retrospective analysis.
    Zajecka JM; Jeffries H; Fawcett J
    J Clin Psychiatry; 1995 Aug; 56(8):338-43. PubMed ID: 7635848
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible synergism between fluoxetine and lithium in refractory depression.
    Pope HG; McElroy SL; Nixon RA
    Am J Psychiatry; 1988 Oct; 145(10):1292-4. PubMed ID: 3262313
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A double-blind, randomized, placebo-controlled trial of fluoxetine in children and adolescents with depression.
    Emslie GJ; Rush AJ; Weinberg WA; Kowatch RA; Hughes CW; Carmody T; Rintelmann J
    Arch Gen Psychiatry; 1997 Nov; 54(11):1031-7. PubMed ID: 9366660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fluoxetine in tricyclic refractory major depressive disorder.
    Beasley CM; Sayler ME; Cunningham GE; Weiss AM; Masica DN
    J Affect Disord; 1990 Nov; 20(3):193-200. PubMed ID: 2148340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A controlled study of trazodone, imipramine, and placebo in outpatients with endogenous depression.
    Mann JJ; Georgotas A; Newton R; Gershon S
    J Clin Psychopharmacol; 1981 Mar; 1(2):75-80. PubMed ID: 7028798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.